Resmed RMD
NYSE RMD
$231.52 +3.08 (+1.35%)
At close: Aug 21, 2026 · 4:00 PM EDT

Resmed (RMD) Cash from Operations Growth (1y) (2010 - 2026)

Resmed (RMD) Cash from Operations Growth (1y) (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (1y) (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn 48.31%
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn -28.74%
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn 0.99%
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn -15.62%
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn 262.94%
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn -29.98%
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn 34.32%
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn 90.02%
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn -4.50%
10 Align Technology 11.61 Bn 10.51 Bn 757.43 Mn 49.83%

Historic Data

Download Data
DateValue
Jun 30, 2026 -15.62%
Mar 31, 2026 -4.24%
Dec 31, 2025 10.08%
Sep 30, 2025 40.48%
Jun 30, 2025 22.42%
Mar 31, 2025 43.93%
Dec 31, 2024 13.12%
Sep 30, 2024 13.71%
Jun 30, 2024 85.36%
Mar 31, 2024 42.28%
Dec 31, 2023 112.10%
Sep 30, 2023 541.00%
Jun 30, 2023 198.71%
Mar 31, 2023 140.61%
Dec 31, 2022 -41.50%
Sep 30, 2022 168.02%
Jun 30, 2022 -64.91%
Mar 31, 2022 -40.17%
Dec 31, 2021 29.40%
Sep 30, 2021 -145.60%